Clearside Biomedical Stock Predictions

Healthcare > Biotechnology

Buy CLSD

*Your capital is at risk

$0.410

+0 (+0%)

At Close: Mar 13, 2026

Currently predicting for Mon, 8 Jun 2026

CLSD Prediction Chart

CLSD Predictions History

Latest community submissions for CLSD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Mar 7, 2025	$0.95 -2.89%	$0.93	V	97.84%	1
PredictionBot.Warren Pro	Mar 7, 2025	$0.96 -1.81%	$0.93	V	96.70%	1
kevinkinchen	Mar 7, 2025	$1.33 +36.26%	$0.93	X	56.65%	0
henrysobo63	Jul 20, 2023	Bearish	$1.24	X	—	0
rleonid Amateur	Jul 27, 2021	$4.86 -4.14%	$5.07	X	95.86%	0
rleonid Amateur	Jul 26, 2021	$5.20 +4.00%	$5.00	X	96.00%	0
rleonid Amateur	Jul 22, 2021	$5.90 +9.87%	$5.37	X	90.13%	0
JS Pro	Jul 14, 2021	$5.76 +8.47%	$5.31	X	91.53%	1
mpits9984	Jul 14, 2021	Bullish	$5.31	X	—	0
JS Pro	Jul 6, 2021	$5.57 +0.54%	$5.54	X	99.46%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLSD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CLEARSIDE BIOMEDICAL, INC

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an i...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by